An Antimicrobial Blue Light Prototype Device Controls Infected Wounds in a Preclinical Porcine Model
The Journal of Infectious Diseases · 17.03.2025 · 231 (3) · e545-e552
DOI: 10.1093/infdis/jiae548 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 13.11.2024. Verfasst von Laisa Bonafim Negri und 12 weiteren Autor:innen. Beteiligte Einrichtung: Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Wound Infection, Staphylococcal Infections, Light. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, Edmund C. Lynch, Jr Research Fund, NIDCR NIH HHS.
Abstract (Originalsprache)
We developed a translational prototype antimicrobial blue light (ABL) device for treating skin wounds with ABL. Partial-thickness surgical wounds were created in live swine (an animal whose skin is considered the most like human skin), then heavily contaminated and left untreated for 24 hours with methicillin-resistant Staphylococcus aureus (MRSA). ABL treatment stabilized and reduced MRSA infection by greater than 4 orders of magnitude (>99.99%; P < .0001) compared with untreated wounds in the same animal, after only 2 daily treatments. These data support further development of such devices for controlling infection in skin wounds. ABL, with or without concomitant administration of negative pressure, antimicrobials, or photosensitizers, could play an important role in modern wound care by reducing the amount, duration, and cost of antibiotics needed, helping reduce antimicrobial resistance. No such device for treating human cutaneous wounds currently exists. This deserves further development and study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Vaccine and Immunotherapy Center, Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Massachusetts General Hospital, Department of Dermatology, Boston, Massachusetts, USA.
- Harvard Medical School, Department of Dermatology, Boston, Massachusetts, USA.
- Massachusetts General Hospital, Department of Medicine, Boston, Massachusetts, USA.
- Harvard Medical School, Department of Medicine, Boston, USA.
ORCID-Profile: Laisa Bonafim Negri, William Farinelli, Sandeep Korupolu, Hang Lee, Pu-Ting Dong, Joshua Tam, Jeffrey A Gelfand
Förderung
- NIH HHS
- Edmund C. Lynch, Jr Research Fund
- NIDCR NIH HHS
- Harvard University
- NCATS NIH HHS
- National Center for Advancing Translational Sciences
- NIH
Zitieren
APA
Negri, L. B., Farinelli, W., Korupolu, S., Wang, Y., Mannaa, Y., Lee, H., Hui, J., Dong, P. T., Slate, A., Tam, J., Anderson, R. R., Yun, S. A., & Gelfand, J. A. (2025). An Antimicrobial Blue Light Prototype Device Controls Infected Wounds in a Preclinical Porcine Model. The Journal of Infectious Diseases, 231(3), e545-e552. https://doi.org/10.1093/infdis/jiae548
Vancouver
Negri LB, Farinelli W, Korupolu S, Wang Y, Mannaa Y, Lee H, et al. An Antimicrobial Blue Light Prototype Device Controls Infected Wounds in a Preclinical Porcine Model. The Journal of Infectious Diseases. 2025;231(3):e545-e552. doi:10.1093/infdis/jiae548
BibTeX
@article{Negri2025,
author = {Negri, Laisa Bonafim and Farinelli, William and Korupolu, Sandeep and Wang, Ying and Mannaa, Yara and Lee, Hang and Hui, Jie and Dong, Pu-Ting and Slate, Andrea and Tam, Joshua and Anderson, R Rox and Yun, Seok-Hyun Andy and Gelfand, Jeffrey A},
title = {An Antimicrobial Blue Light Prototype Device Controls Infected Wounds in a Preclinical Porcine Model},
journal = {The Journal of Infectious Diseases},
year = {2025},
volume = {231},
number = {3},
pages = {e545--e552},
doi = {10.1093/infdis/jiae548}
}
EUVIMED